Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1978 Apr;62(4):579–589. doi: 10.1111/j.1476-5381.1978.tb07765.x

A 5-hydroxytryptamine-like mode of anorectic action for 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212).

B V Clineschmidt, J C McGuffin, A B Pflueger, J A Totaro
PMCID: PMC1668036  PMID: 656703

Abstract

The mechanism of the reduction in food consumption elicited by 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) administered systemically was investigated in the rat. (+/-)-Fenfluramine and (+)-amphetamine were included in some studies for comparative purposes. 2 Pretreatment with methergoline, a 5-hydroxytryptamine (5-HT) antagonist, reduced the magnitude of the anorectic effect of 1.5 and 3 mg/kg of MK-212, while the anti-5-HT agents, cyproheptadine and cinanserin, were likewise effective against the 3 mg/kg dose. 3 Xylamidine, an antagonist of 5-HT that penetrates poorly into the central nervous system, completely blocked the decrease in food intake caused by 5-HT administered peripherally, while not antagonizing an equianorectic dose of MK-212. 4 Reduction of brain 5-HT by intraventricular injection of 5,6-dihydroxytryptamine, intraperitoneal administration of p-chloroamphetamine or placement of a lesion in the region of the median raphé nucleus diminished the anorectic response to 3 mg/kg of MK-212. The anorectic effect of amphetamine was reduced by p-chloroamphetamine or lesion in the raphé, but not by 5,6-dihydroxytryptamine. The decrease in food consumption produced by 1.5 mg/kg of MK-212 was antagonized by prior treatment with p-chloroamphetamine, but not by 5,6-dihydroxytryptamine. 5 Haloperidol, which blocks receptors for dopamine, antagonized the anorexigenic effect of amphetamine, but was ineffective in offsetting the action of MK-212, 3 mg/kg. 6 Pretreatment with chlorimipramine to inhibit the 5-hydroxytryptaminergic uptake mechanism did not affect the anorectic response to 3 mg/kg of MK-212, whereas the response to fenfluramine was diminished. 7 The results indicate that the anorectic action of MK-212 involves a 5-HT-like component which is more evident at the higher dose level of the compound. The anorexigenic property of MK-212 may depend, at least partly, upon the integrity of 5-HT-containing neurones in the central nervous system.

Full text

PDF
579

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANTON A. H., SAYRE D. F. A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther. 1962 Dec;138:360–375. [PubMed] [Google Scholar]
  2. BOGDANSKI D. F., PLETSCHER A., BRODIE B. B., UNDENFRIEND S. Identification and assay of serotonin in brain. J Pharmacol Exp Ther. 1956 May;117(1):82–88. [PubMed] [Google Scholar]
  3. Baumgarten H. G., Björklund A., Lachenmayer L., Nobin A., Stenevi U. Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine. Acta Physiol Scand Suppl. 1971;373:1–15. [PubMed] [Google Scholar]
  4. Beretta C., Glässer A. H., Nobili M. B., Silvestri R. Antagonism of 5-hydroxytryptamine-induced bronchospasm in guinea-pigs by 8-beta-carbobenzyloxyaminomethyl-1-methyl-10-alpha-ergoline. J Pharm Pharmacol. 1965 Jul;17(7):423–428. doi: 10.1111/j.2042-7158.1965.tb07697.x. [DOI] [PubMed] [Google Scholar]
  5. Brase D. A., Loh H. H. Possible role of 5-hydroxyptamine in minimal brain dysfunction. Life Sci. 1975 Apr 1;16(7):1005–1015. doi: 10.1016/0024-3205(75)90184-8. [DOI] [PubMed] [Google Scholar]
  6. Carlsson A. Structural specificity for inhibition of [14C]-5-hydroxytryptamine uptake by cerebral slices. J Pharm Pharmacol. 1970 Oct;22(10):729–732. doi: 10.1111/j.2042-7158.1970.tb08419.x. [DOI] [PubMed] [Google Scholar]
  7. Clineschmidt B. V. 5,6-Dihydroxytryptamine: suppression of the anorexigenic action of fenfluramine. Eur J Pharmacol. 1973 Dec;24(3):405–409. doi: 10.1016/0014-2999(73)90170-2. [DOI] [PubMed] [Google Scholar]
  8. Clineschmidt B. V., Lotti V. J. Indoleamine antagonists: relative potencies as inhibitors of tryptamine- and 5-hydroxytryptophan-evoked responses. Br J Pharmacol. 1974 Feb;50(2):311–313. doi: 10.1111/j.1476-5381.1974.tb08577.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Clineschmidt B. V., Mcguffin J. C., Werner A. B. Role of monoamines in the anorexigenic actions of fenfluramine, amphetamine and p-chloromethamphetamine. Eur J Pharmacol. 1974 Aug;27(3):313–323. doi: 10.1016/0014-2999(74)90006-5. [DOI] [PubMed] [Google Scholar]
  10. Clineschmidt B. V., Totaro J. A., McGuffin J. C., Pflueger A. B. Fenfluramine: long-term reduction in brain serotonin (5-hydroxytryptamine). Eur J Pharmacol. 1976 Jan;35(1):211–214. doi: 10.1016/0014-2999(76)90318-6. [DOI] [PubMed] [Google Scholar]
  11. Copp F. C., Green A. F., Hodson H. F., Randall A. W., Sim M. F. New peripheral antagonists of 5-hydroxytryptamine. Nature. 1967 Apr 8;214(5084):200–201. doi: 10.1038/214200a0. [DOI] [PubMed] [Google Scholar]
  12. Duhault J., Boulanger M., Voisin C., Malen C., Schmitt H. Fenfluramine and 5-hydroxytryptamine. Part 2: Involvement of brain 5-hydroxytryptamine in the anorectic activity of fenfluramine. Arzneimittelforschung. 1975 Nov;25(11):1758–1762. [PubMed] [Google Scholar]
  13. Ferrini R., Glässer A. Antagonism of central effects of tryptamine and 5-hydroxytryptophan by 1,6-dimethyl-8beta-carbobenzyloxy-aminomethyl-10alpha-ergoline. Interference with amphetamine and DOPA. Psychopharmacologia. 1965 Nov 16;8(4):271–276. doi: 10.1007/BF00407859. [DOI] [PubMed] [Google Scholar]
  14. Fuller R. W., Perry K. W., Molloy B. B. Effect of 3-(p-trifluoromethylphenoxy). N. N. methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine. J Pharmacol Exp Ther. 1975 Jun;193(3):793–803. [PubMed] [Google Scholar]
  15. Funderburk W. H., Hazelwood J. C., Ruckart R. T., Ward J. W. Is 5-hydroxytryptamine involved in the mechanism of action of fenfluramine? J Pharm Pharmacol. 1971 Jun;23(6):468–470. doi: 10.1111/j.2042-7158.1971.tb08690.x. [DOI] [PubMed] [Google Scholar]
  16. Fuxe K., Farnebo L. O., Hamberger B., Ogren S. O. On the in vivo and in vitro actions of fenfluramine and its derivatives on central monoamine neurons, especially 5-hydroxytryptamine neurons, and their relation to the anorectic activity of fenfluramine. Postgrad Med J. 1975;51 (Suppl 1):35–45. [PubMed] [Google Scholar]
  17. Garattini S., Buczko W., Jori A., Samanin R. The mechanism of action of fenfluramine. Postgrad Med J. 1975;51 (Suppl 1):27–35. [PubMed] [Google Scholar]
  18. Harvey J. A., McMaster S. E. Fenfluramine: evidence for a neurotoxic action on midbrain and a long-term depletion of serotonin. Psychopharmacol Commun. 1975;1(2):217–228. [PubMed] [Google Scholar]
  19. Hollister A. S., Ervin G. N., Cooper B. R., Breese G. R. The roles of monoamine neural systems in the anorexia induced by(+)-amphetamine and related compounds. Neuropharmacology. 1975 Oct;14(10):715–723. doi: 10.1016/0028-3908(75)90096-9. [DOI] [PubMed] [Google Scholar]
  20. Holtzman S. G., Jewett R. E. The role of brain norepinephrine in the anorexic effects of dextroamphetamine and monoamine oxidase inhibitors in the rat. Psychopharmacologia. 1971;22(2):151–161. doi: 10.1007/BF00403623. [DOI] [PubMed] [Google Scholar]
  21. Jespersen S., Scheel-Krüger J. Evidence for a difference in mechanism of action between fenfluramine- and amphetamine-induced anorexia. J Pharm Pharmacol. 1973 Jan;25(1):49–54. doi: 10.1111/j.2042-7158.1973.tb09114.x. [DOI] [PubMed] [Google Scholar]
  22. Joy R. J., Emma C. P., Mayer J. New rat feeding jar: use in study of relationships of food intake and body weight. J Appl Physiol. 1967 Oct;23(4):589–590. doi: 10.1152/jappl.1967.23.4.589. [DOI] [PubMed] [Google Scholar]
  23. Mawson C., Whittington H. Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents. Br J Pharmacol. 1970 May;39(1):223P–224P. [PMC free article] [PubMed] [Google Scholar]
  24. Neckers L. M., Bertilsson L., Koslow S. H., Meek J. L. Reduction of tryptophan hydroxylase activity and 5-hydroxytryptamine concentration in certain rat brain nuclei after p-chloroamphetamine. J Pharmacol Exp Ther. 1976 Feb;196(2):333–338. [PubMed] [Google Scholar]
  25. Noble E. P., Wurtman R. J., Axelrod J. A simple and rapid method for injecting H3-norepinephrine into the lateral ventricle of the rat brain. Life Sci. 1967 Feb 1;6(3):281–291. doi: 10.1016/0024-3205(67)90157-9. [DOI] [PubMed] [Google Scholar]
  26. Pinder R. M., Brogden R. N., Sawyer P. R., Speight T. M., Avery G. S. Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity. Drugs. 1975;10(4):241–323. doi: 10.2165/00003495-197510040-00001. [DOI] [PubMed] [Google Scholar]
  27. Porter C. C., Totaro J. A., Burcin A. The relationship between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labeled methyldopa or 6-hydroxydopamine. J Pharmacol Exp Ther. 1965 Oct;150(1):17–22. [PubMed] [Google Scholar]
  28. RUBIN B., PIALA J. J., BURKE J. C., CRAVER B. N. A NEW, POTENT AND SPECIFIC SEROTONIN INHIBITOR, (SQ 10,643) 2'-(3-DIMETHYLAMINOPROPYLTHIO) CINNAMANILIDE HYDROCHLORIDE: ANTISEROTONIN ACTIVITY ON UTERUS AND ON GASTROINTESTINAL, VASCULAR, AND RESPIRATORY SYSTEMS OF ANIMALS. Arch Int Pharmacodyn Ther. 1964 Nov 1;152:132–143. [PubMed] [Google Scholar]
  29. Samanin R., Ghezzi D., Valzelli L., Garattini S. The effects of selective lesioning of brain serotonin or catecholamine containing neurones on the anorectic activity of fenfluramine and amphetamine. Eur J Pharmacol. 1972 Sep;19(3):318–322. doi: 10.1016/0014-2999(72)90097-0. [DOI] [PubMed] [Google Scholar]
  30. Sanders-Bush E., Bushing J. A., Sulser F. Long-term effects of p-chloroamphetamine on tryptophan hydroxylase activity and on the levels of 5-hydroxytryptamine and 5-hydroxyindole acetic acid in brain. Eur J Pharmacol. 1972 Dec;20(3):385–388. doi: 10.1016/0014-2999(72)90204-x. [DOI] [PubMed] [Google Scholar]
  31. Sastry B. S., Phillis J. W. Metergoline as a selective 5-hydroxytryptamine antagonist in the cerebral cortex. Can J Physiol Pharmacol. 1977 Feb;55(1):130–133. doi: 10.1139/y77-020. [DOI] [PubMed] [Google Scholar]
  32. Sugrue M. F., Goodlet I., McIndewar I. Failure of depletion of rat brain 5-hydroxytryptamine to alter fenfluramine-induced anorexia. J Pharm Pharmacol. 1975 Dec;27(12):950–953. doi: 10.1111/j.2042-7158.1975.tb10255.x. [DOI] [PubMed] [Google Scholar]
  33. Weissman A., Koe B. K., Tenen S. S. Antiamphetamine effects following inhibition of tyrosine hydroxylase. J Pharmacol Exp Ther. 1966 Mar;151(3):339–352. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES